ARG66903
anti-SARS-CoV / SARS-CoV-2 Spike protein (RBD) antibody [CR3022]
anti-SARS-CoV / SARS-CoV-2 Spike protein (RBD) antibody [CR3022] for ELISA,Neutralizing and Virus
Overview
Product Description | Recombinant Human Monoclonal antibody [CR3022] recognizes SARS-CoV / SARS-CoV-2 Spike protein (RBD) |
---|---|
Tested Reactivity | Virus |
Tested Application | ELISA, Neut |
Host | Human |
Clonality | Monoclonal |
Clone | CR3022 |
Isotype | IgA |
Target Name | SARS-CoV / SARS-CoV-2 Spike protein (RBD) |
Antigen Species | Virus |
Conjugation | Un-conjugated |
Application Instructions
Application Suggestion |
|
||||||
---|---|---|---|---|---|---|---|
Application Note | Neutralizing: Clone CR3022 is the first anti-SARS-CoV neutralizing antibody to cross-react with SARS-CoV-2. Structural modeling has confirmed that CR3022 targets a conserved epitope between SARS-CoV and SARS-CoV2 in the RBD domain (PMID: 32245784, 32065055). * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. |
Properties
Form | Liquid |
---|---|
Purification | Purified from antibody expressing HEK293 cell culture medium. |
Purity | > 95% (SDS-PAGE) |
Buffer | PBS (pH 7.4) |
Concentration | 1 mg/ml |
Storage Instruction | For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. |
Note | For laboratory research only, not for drug, diagnostic or other use. |